CA1320730C
(en)
*
|
1987-10-16 |
1993-07-27 |
The Du Pont Merck Pharmaceutical Company |
Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
|
US5231188A
(en)
*
|
1989-11-17 |
1993-07-27 |
The Upjohn Company |
Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
|
WO1993009103A1
(en)
*
|
1991-11-01 |
1993-05-13 |
The Upjohn Company |
Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
|
SK283420B6
(sk)
*
|
1992-05-08 |
2003-07-01 |
Pharmacia & Upjohn Company |
Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
|
JP3558088B2
(ja)
*
|
1992-12-08 |
2004-08-25 |
ファルマシア・アンド・アップジョン・カンパニー |
トロポン−置換のフェニルオキサゾリジノン抗菌剤
|
MY115155A
(en)
*
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
US5688792A
(en)
*
|
1994-08-16 |
1997-11-18 |
Pharmacia & Upjohn Company |
Substituted oxazine and thiazine oxazolidinone antimicrobials
|
ES2133588T3
(es)
*
|
1993-11-22 |
1999-09-16 |
Upjohn Co |
Esteres de hidroxiacetil-piperazin-fenil-oxazolidinonas sustituidas.
|
JPH0873455A
(ja)
*
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
US5668286A
(en)
*
|
1994-03-15 |
1997-09-16 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
DE4425612A1
(de)
*
|
1994-07-20 |
1996-04-04 |
Bayer Ag |
6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
|
DE4425613A1
(de)
*
|
1994-07-20 |
1996-01-25 |
Bayer Ag |
5-gliedrige Heteroaryl-oxazolidinone
|
WO1996013502A1
(en)
*
|
1994-10-26 |
1996-05-09 |
Pharmacia & Upjohn Company |
Phenyloxazolidinone antimicrobials
|
DK0710657T3
(da)
|
1994-11-02 |
1999-05-25 |
Merck Patent Gmbh |
Adhæsionsreceptor-antagonister
|
NZ295528A
(en)
*
|
1994-11-15 |
1999-03-29 |
Upjohn Co |
Bicyclic oxazine and thiazine oxazolidinone antibacterials
|
US5688808A
(en)
|
1994-12-22 |
1997-11-18 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
US6696459B1
(en)
|
1994-12-22 |
2004-02-24 |
Ligand Pharmaceuticals Inc. |
Steroid receptor modulator compounds and methods
|
ES2163004T3
(es)
*
|
1995-02-03 |
2002-01-16 |
Upjohn Co |
Feniloxazolidinona sustituida por un anillo heteroaromatico como agente antimicrobiano.
|
AU702752B2
(en)
*
|
1995-05-11 |
1999-03-04 |
Pharmacia & Upjohn Company |
Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
|
KR100463772B1
(ko)
|
1995-09-01 |
2005-11-09 |
파마시아 앤드 업존 캄파니 엘엘씨 |
4내지8원헤테로사이클릭환에탄소-탄소결합을갖는페닐옥사졸리디논
|
US5883093A
(en)
*
|
1995-09-12 |
1999-03-16 |
Pharmacia & Upjohn Company |
Phenyloxazolidinone antimicrobials
|
GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
HRP970049A2
(en)
*
|
1996-02-06 |
1998-04-30 |
Bayer Ag |
New heteroaryl oxazolidinones
|
DE19604223A1
(de)
*
|
1996-02-06 |
1997-08-07 |
Bayer Ag |
Neue substituierte Oxazolidinone
|
GB9702213D0
(en)
*
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
MY116093A
(en)
*
|
1996-02-26 |
2003-11-28 |
Upjohn Co |
Azolyl piperazinyl phenyl oxazolidinone antimicrobials
|
GB9604301D0
(en)
*
|
1996-02-29 |
1996-05-01 |
Zeneca Ltd |
Chemical compounds
|
US6107519A
(en)
*
|
1997-11-07 |
2000-08-22 |
Pharmacia & Upjohn Company |
Process to produce oxazolidinones
|
CN1167701C
(zh)
*
|
1996-04-11 |
2004-09-22 |
法玛西雅厄普约翰美国公司 |
制备噁唑烷酮胺的方法
|
GB9609919D0
(en)
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
EP0920421B1
(en)
*
|
1996-08-21 |
2002-11-06 |
PHARMACIA & UPJOHN COMPANY |
Isoxazoline derivatives useful as antimicrobials
|
SK156499A3
(en)
|
1997-05-30 |
2000-06-12 |
Upjohn Co |
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
|
US6255304B1
(en)
|
1997-05-30 |
2001-07-03 |
Pharmacia & Upjohn Company |
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
|
JP2002513424A
(ja)
*
|
1997-07-11 |
2002-05-08 |
ファルマシア・アンド・アップジョン・カンパニー |
チアジアゾリルおよびオキサジアゾリルフェニルオキサゾリジノン抗菌剤
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717807D0
(en)
*
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
CA2303959A1
(en)
*
|
1997-11-12 |
1999-05-20 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions
|
GB9725244D0
(en)
*
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
US6083967A
(en)
|
1997-12-05 |
2000-07-04 |
Pharmacia & Upjohn Company |
S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones
|
EP1049682A1
(en)
|
1998-01-23 |
2000-11-08 |
Versicor, Inc. |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
NZ506292A
(en)
*
|
1998-02-13 |
2003-05-30 |
Upjohn Co |
Substituted aminophenyl isoxazoline methylamide derivatives useful as antimicrobials
|
IL140084A0
(en)
*
|
1998-06-05 |
2002-02-10 |
Astra Ab |
Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
|
US6420349B1
(en)
|
1998-08-24 |
2002-07-16 |
Bristol-Myers Squibb Company |
Isoxazolinone antibacterial agents
|
AU1379900A
(en)
*
|
1998-11-17 |
2000-06-05 |
Bayer Aktiengesellschaft |
Novel substituted phenyloxazolidone derivatives
|
AU4224699A
(en)
|
1999-01-27 |
2000-08-18 |
Pharmacia & Upjohn Company |
Assays for modulators of elongation factor p activity
|
KR100333492B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 메틸렌 옥사졸리디논 유도체 및 이의 제조방법
|
KR100333493B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 카르보닐 옥사졸리디논 유도체 및 이의 제조방법
|
IL147503A0
(en)
|
1999-07-28 |
2002-08-14 |
Upjohn Co |
Oxazolidinone compounds and methods of preparation and use thereof
|
WO2001019366A1
(en)
*
|
1999-09-13 |
2001-03-22 |
Insite Vision Incorporated |
Topical treatment for prevention of ocular infections
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
US6451345B1
(en)
*
|
2000-01-20 |
2002-09-17 |
Eurand Pharmaceuticals Ltd. |
Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
|
GB0009803D0
(en)
*
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
KR100731469B1
(ko)
*
|
2000-06-05 |
2007-06-21 |
동아제약주식회사 |
피리딘 고리를 포함하는 옥사졸리디논 유도체 및 그의제조방법
|
US6465456B2
(en)
|
2000-06-29 |
2002-10-15 |
Bristol-Myers Squibb Company |
Isoxazolinone antibacterial agents
|
US6734307B2
(en)
|
2000-07-17 |
2004-05-11 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
DE60118241T2
(de)
*
|
2000-10-17 |
2006-12-28 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
Verfahren zur herstellung von oxazolidinonverbindungen
|
US6689769B2
(en)
*
|
2000-12-21 |
2004-02-10 |
Pharmacia & Upjohn Company |
Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
CN1639136A
(zh)
|
2001-09-11 |
2005-07-13 |
阿斯特拉曾尼卡有限公司 |
作为抗菌剂的噁唑烷酮和/或异噁唑啉
|
WO2004026848A1
(en)
*
|
2002-09-20 |
2004-04-01 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
US20060116400A1
(en)
*
|
2002-11-28 |
2006-06-01 |
Astrazeneca Ab |
Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
|
GB0229521D0
(en)
*
|
2002-12-19 |
2003-01-22 |
Astrazeneca Ab |
Chemical compounds
|
DE10300111A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
TW200500360A
(en)
*
|
2003-03-01 |
2005-01-01 |
Astrazeneca Ab |
Hydroxymethyl compounds
|
GB0306358D0
(en)
*
|
2003-03-20 |
2003-04-23 |
Astrazeneca Ab |
Chemical compounds
|
AR044152A1
(es)
|
2003-05-09 |
2005-08-24 |
Bayer Corp |
Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
|
WO2005012271A2
(en)
*
|
2003-07-29 |
2005-02-10 |
Rib-X Pharmaceuticals, Inc. |
Process for the synthesis of biaryl oxazolidinones
|
US8324398B2
(en)
|
2003-06-03 |
2012-12-04 |
Rib-X Pharmaceuticals, Inc. |
Process for the synthesis of biaryl oxazolidinones
|
PL1656370T3
(pl)
|
2003-06-03 |
2013-03-29 |
Melinta Subsidiary Corp |
Biarylowe związki heterocykliczne oraz sposoby ich wytwarzania i stosowania
|
EP1646617A2
(en)
*
|
2003-06-03 |
2006-04-19 |
Rib-X Pharmaceuticals, Inc. |
Sulfonamide compounds and methods of making and using the same
|
WO2005005420A1
(en)
*
|
2003-07-02 |
2005-01-20 |
Merck & Co., Inc. |
Cyclopropyl group substituted oyazolidinone antibiotics and derivatives thereof
|
JP4607107B2
(ja)
*
|
2003-07-02 |
2011-01-05 |
メルク・シャープ・エンド・ドーム・コーポレイション |
シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体
|
JP2007500707A
(ja)
*
|
2003-07-29 |
2007-01-18 |
リブ−エックス ファーマシューティカルズ,インコーポレイテッド |
ビアリールヘテロ環状のアミン、アミドおよび硫黄−含有化合物、並びに該化合物の製造方法および使用方法
|
ES2536001T3
(es)
*
|
2003-07-29 |
2015-05-19 |
Melinta Therapeutics, Inc. |
Procedimiento para la síntesis de biariloxazolidinonas
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
TW200526649A
(en)
*
|
2003-12-17 |
2005-08-16 |
Rib X Pharmaceuticals Inc |
Halogenated biaryl heterocyclic compounds and methods of making and using the same
|
KR100854211B1
(ko)
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
JP2008508271A
(ja)
*
|
2004-07-28 |
2008-03-21 |
リブ−エックス ファーマシューティカルズ,インコーポレイテッド |
ビアリール複素環式化合物ならびにその化合物を製造および使用する方法
|
DE102004062475A1
(de)
*
|
2004-12-24 |
2006-07-06 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
|
EP1685841A1
(en)
*
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
EP1866295A2
(en)
|
2005-02-24 |
2007-12-19 |
Teva Pharmaceutical Industries Ltd |
Processes for the preparation of linezolid intermediate
|
US8399660B2
(en)
*
|
2005-06-08 |
2013-03-19 |
Rib-X Pharmaceuticals, Inc. |
Process for the synthesis of triazoles
|
DE102005045518A1
(de)
*
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
SG166126A1
(en)
|
2005-10-04 |
2010-11-29 |
Bayer Schering Pharma Ag |
Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
DE102005047558A1
(de)
*
|
2005-10-04 |
2008-02-07 |
Bayer Healthcare Ag |
Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
|
WO2007102082A1
(en)
*
|
2006-03-09 |
2007-09-13 |
Glenmark Pharmaceuticals Limited |
High oxazolidinone content solid dosage forms
|
WO2007133803A2
(en)
*
|
2006-05-15 |
2007-11-22 |
Rib-X Pharmaceuticals, Inc. |
Treatment of mycobacterial infections
|
WO2008021849A2
(en)
|
2006-08-09 |
2008-02-21 |
Smithkline Beecham Corporation |
Novel compounds as antagonists or inverse agonists at opioid receptors
|
NZ587096A
(en)
|
2008-03-26 |
2011-11-25 |
Global Alliance For Tb Drug Dev |
Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
|
US8575337B2
(en)
|
2008-06-24 |
2013-11-05 |
Research Foundation Itsuu Laboratory |
Oxazolidinone derivative having fused ring
|
KR101023174B1
(ko)
*
|
2008-09-24 |
2011-03-18 |
주식회사 레고켐 바이오사이언스 |
사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
|
EP2757104B1
(en)
|
2008-10-10 |
2019-08-14 |
Merck Sharp & Dohme Corp. |
Compounds used in the synthesis of oxazolidinones
|
EP2393808B1
(en)
|
2009-02-03 |
2019-05-08 |
Merck Sharp & Dohme Corp. |
Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
|
US8580767B2
(en)
*
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
EP2635589A1
(en)
|
2010-11-03 |
2013-09-11 |
Wockhardt Limited |
Process for the preparation of phosphoric acid mono- (l-{4- [(s) -5- (acetylaminomethyl) - 2 - oxo - oxazolidin- 3 - yl]- 2, 6 - difluorophenyl} - 4 -methoxymethylpiperidin- 4 - yl) ester
|
CN103896963B
(zh)
*
|
2012-12-26 |
2017-06-09 |
中国科学院上海药物研究所 |
苯并噁嗪噁唑烷酮类化合物及其制备方法和用途
|
US9862710B2
(en)
|
2013-03-15 |
2018-01-09 |
Istituto Euro Mediterraneo Di Scienza E Tecnologia |
1,2,4-oxadiazol compounds active against gram-positive pathogens
|
PL2970244T3
(pl)
*
|
2013-03-15 |
2020-01-31 |
Università Degli Studi Di Milano - Bicocca |
Nowe związki 1,2,4-oksadiazolu aktywne względem patogenów Gram-dodatnich
|
ITRM20130155A1
(it)
*
|
2013-03-15 |
2014-09-16 |
I E Me S T Istituto Euro Mediter Raneo Di Scien |
Nuovi composti 1,2,4-ossadiazolici attivi contro patogeni gram-positivi.
|
CN103965183B
(zh)
*
|
2014-03-17 |
2017-05-03 |
上海应用技术学院 |
一种含氟噁唑烷酮类化合物及其制备方法和应用
|
WO2015173664A1
(en)
|
2014-05-14 |
2015-11-19 |
Wockhardt Limited |
Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
|
WO2017066964A1
(en)
*
|
2015-10-22 |
2017-04-27 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compounds and methods of use thereof as antibacterial agents
|
CN106083994B
(zh)
*
|
2016-04-18 |
2019-12-06 |
南京曼杰生物科技有限公司 |
取代的噁唑烷酮水溶性衍生物及其应用
|